Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 12.69
-0.09 (-0.70%)
Aug 14, 2026, 3:04 PM CST
SHE:300601 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,659 | 2,673 | 2,652 | 3,477 | 3,157 | 3,652 |
Revenue Growth | -6.55% | 0.81% | -23.75% | 10.14% | -13.54% | 61.51% |
Gross Profit Gross Profit Growth | 1,840 | 1,865 | 1,951 | 2,822 | 2,382 | 2,504 |
Operating Income Operating Income Growth | 26.24 | 41.44 | 129.98 | 778.26 | 205.13 | 1,300 |
Net Income Net Income Growth | 81.24 | 70.33 | 201.65 | 861.3 | -132.71 | 1,263 |
Earnings Per Share EPS Growth | 0.07 | 0.06 | 0.18 | 0.77 | -0.12 | 1.14 |
EPS Growth | -53.82% | -66.67% | -76.62% | - | - | 80.18% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Biological Products Biological Products Growth | 2,594 | 2,607 | 3,466 | 3,129 | 3,650 |
Housing Rental Housing Rental Growth | 68.77 | 36.76 | - | - | - |
Other Other Growth | 10.43 | 8 | 11.16 | - | - |
Total Total Growth | 2,673 | 2,652 | 3,477 | 3,157 | 3,652 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,881 | 2,662 | 2,607 | 1,759 | 1,990 | 4,275 |
Total Debt Total Debt Growth | 1,927 | 1,887 | 2,024 | 2,465 | 2,289 | 2,738 |
Net Cash (Debt) Net Cash Growth | -46.13 | 775.57 | 583.32 | -705.64 | -299.34 | 1,537 |
Net Cash Growth | - | 32.96% | - | - | - | -47.84% |
Net Cash Per Share Net Cash Per Share Growth | -0.04 | 0.66 | 0.52 | -0.63 | -0.27 | 1.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 582.6 | 635.57 | 603.25 | 1,033 | 545.7 | 1,652 |
Capital Expenditures CapEx Growth | -337 | -331.92 | -472.18 | -718.45 | -1,310 | -2,540 |
Free Cash Flow Free Cash Flow Growth | 245.6 | 303.65 | 131.07 | 314.65 | -764.7 | -888.15 |
Free Cash Flow Growth | 9.48% | 131.67% | -58.34% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 69.19% | 69.77% | 73.58% | 81.16% | 75.45% | 68.57% |
Operating Margin | 0.99% | 1.55% | 4.90% | 22.38% | 6.50% | 35.60% |
Pretax Margin | 2.20% | 1.70% | 5.65% | 27.04% | -10.71% | 39.41% |
Profit Margin | 3.06% | 2.63% | 7.61% | 24.77% | -4.20% | 34.59% |
FCF Margin | 9.24% | 11.36% | 4.94% | 9.05% | -24.22% | -24.32% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.035 | 0.035 | 0.090 | 0.380 | - | 0.719 |
Dividend Per Share Growth | -61.11% | -61.11% | -76.32% | - | - | 283.36% |
Dividend Yield | 0.28% | 0.24% | 0.53% | 1.43% | - | 1.22% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 182.70 | 234.57 | 94.99 | 35.21 | - | 53.59 |
Forward PE | 81.14 | 70.60 | 20.24 | 22.39 | 22.73 | 50.97 |
P/FCF Ratio | 57.71 | 54.33 | 146.15 | 96.37 | - | - |
PS Ratio | 5.33 | 6.17 | 7.22 | 8.72 | 8.63 | 18.54 |